Andrographolide exhibits anti-invasive activity against colon cancer cells via inhibition of MMP2 activity

Planta Medica

Volumn 76, Issue 16, 2010, Pages 1827-1833

  Chao, Hsueh Ping ^a   Kuo, Cheng Deng ^b   Chiu, Jen Hwey ^a   Fu, Shu Ling ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acanthaceae; Andrographis paniculata; andrographolide; anticancer; invasion; MMP2

Indexed keywords

ANDROGRAPHOLIDE; BETA CATENIN; GELATINASE A; INTEGRIN LINKED KINASE; MATRIGEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INVASION; CELL STRAIN HT29; CELL VIABILITY; COLON CANCER; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION;

ANDROGRAPHIS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA CATENIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DITERPENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN-SERINE-THREONINE KINASES;

ACANTHACEAE; ANDROGRAPHIS PANICULATA;

EID: 78349303095     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250039     Document Type: Article

References (35)

1. Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000 100 57-70
2. Gupta G P., Massague J. Cancer metastasis: building a framework. Cell 2006 127 679-695
3. Meyer T, Hart I R. Mechanisms of tumour metastasis. Eur J Cancer 1998 34 214-221
4. Sheng S, Qiao M, Pardee A B. Metastasis and AKT activation. J Cell Physiol 2009 218 451-454
5. Grille S J., Bellacosa A, Upson J, Klein-Szanto A J., van Roy F, Lee-Kwon W, Donowitz M, Tsichlis P N., Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003 63 2172-2178
6. Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 2006 66 3963-3966
7. Reddy K B., Nabha S M., Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003 22 395-403
8. Smalley K S. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer 2003 104 527-532
9. Viala E, Pouyssegur J. Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann NY Acad Sci 2004 1030 208-218
10. Granovsky A E., Rosner M R. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 2008 18 452-457
11. Chiou W F., Chen C F., Lin J J. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol 2000 129 1553-1560
12. Hidalgo M A., Romero A, Figueroa J, Cortes P, Concha I I., Hancke J L., Burgos R A. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. Br J Pharmacol 2005 144 680-686
13. Qin L H., Kong L, Shi G J., Wang Z T., Ge B X. Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases. Biol Pharm Bull 2006 29 220-224
14. Shen Y C., Chen C F., Chiou W F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 2002 135 399-406
15. Xia Y F., Ye B Q., Li Y D., Wang J G., He X J., Lin X, Yao X, Ma D, Slungaard A, Hebbel R P., Key N S., Geng J G. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 2004 173 4207-4217
16. Mehrotra R, Rawat S, Kulshreshtha D K., Patnaik G K., Dhawan B N. In vitro studies on the effect of certain natural products against hepatitis B virus. Indian J Med Res 1990 92 133-138
17. Liang F P., Lin C H., Kuo C D., Chao H P., Fu S L. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway. J Biol Chem 2008 283 5023-5033
18. Rajagopal S, Kumar R A., Deevi D S., Satyanarayana C, Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 2003 3 147-158
19. Sheeja K, Guruvayoorappan C, Kuttan G. Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int Immunopharmacol 2007 7 211-221
20. Zhou J, Zhang S, Ong C N., Shen H M. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol 2006 72 132-144
21. Li J, Cheung H Y., Zhang Z, Chan G K., Fong W F. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol 2007 568 31-44
22. Shi M D., Lin H H., Lee Y C., Chao J K., Lin R A., Chen J H. Inhibition of cell-cycle progression in human colorectal carcinoma LoVo cells by andrographolide. Chem Biol Interact 2008 174 201-210
23. Shi M D., Lin H H., Chiang T A., Tsai L Y., Tsai S M., Lee Y C., Chen J H. Andrographolide could inhibit human colorectal carcinoma LoVo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact 2009 180 344-352
24. Cen L, Hutzen B, Ball S, DeAngelis S, Chen C L., Fuchs J R., Li C, Li P K., Lin J. New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer 2009 9 99
25. Liao H F., Chen Y Y., Liu J J., Hsu M L., Shieh H J., Liao H J., Shieh C J., Shiao M S., Chen Y J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 2003 51 7907-7912
26. Chen M H., Cui S X., Cheng Y N., Sun L R., Li Q B., Xu W F., Ward S G., Tang W, Qu X J. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anticancer Drugs 2008 19 957-965
27. Leeman M F., Curran S, Murray G I. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003 201 528-534
28. Mook O R., Frederiks W M., Van Noorden C J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004 1705 69-89
29. Stahtea X N., Roussidis A E., Kanakis I, Tzanakakis G N., Chalkiadakis G, Mavroudis D, Kletsas D, Karamanos N K. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. Int J Cancer 2007 121 2808-2814
30. Tsai H R., Yang L M., Tsai W J., Chiou W F. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur J Pharmacol 2004 498 45-52
31. Kolch W, Kotwaliwale A, Vass K, Janosch P. The role of Raf kinases in malignant transformation. Expert Rev Mol Med 2002 4 1-18
32. Seguin C A., Pilliar R M., Madri J A., Kandel R A. TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration. Spine 2008 33 356-365
33. Young S C., Wang C J., Lin J J., Peng P L., Hsu J L., Chou F P. Protection effect of piper betel leaf extract against carbon tetrachloride-induced liver fibrosis in rats. Arch Toxicol 2007 81 45-55
34. Roeb E, Bosserhoff A K., Hamacher S, Jansen B, Dahmen J, Wagner S, Matern S. Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways. World J Gastroenterol 2005 11 1096-1104
35. Kohn E C., Liotta L A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995 55 1856-1862